Senior insider sale
ASCENDIS PHARMA A/S — senior position signals high conviction
$41.10M
180.86K shares
What this filing means
MIKKELSEN JAN MOLLER plans to sell 180.86K shares of ASCENDIS PHARMA A/S valued at approximately $41.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001968582-26-000231
180.86K
Shares to sell
$41.10M
Approx. market value
94K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Warrant Exercise
Cash
3/5/2026
94KTotal acquired94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Warrant Exercise Cash | 94K | — |
| Total | 94K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
86.86K
Market value
$18.41M
1/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
94K
Market value
$22.69M
3/5/2026
Total
Units
180.86K
Value
$41.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/13/2026 | 86.86K | $18.41M | — | Completed |
| Planned — Approximate Date | ||||
3/5/2026 | 94K | $22.69M | NASDAQ | Planned |
| Total | 180.86K | $41.10M | ||